Skin
Topical vitamin D analogues (calcipotriol)
Creams and ointments that act on vitamin D receptors in keratinocytes, slowing their proliferation and normalising their maturation; a first-line topical treatment for plaque psoriasis, often combined with a corticosteroid.
Mechanism of action
- Psoriatic plaques are driven by T cells (IL-17, IL-23) that make keratinocytes proliferate too fast and mature abnormally.
- Calcipotriol binds the vitamin D receptor, a nuclear receptor, in keratinocytes.
- It slows proliferation, promotes normal differentiation and dampens local T-cell activity: plaques flatten and scale less.
Molecular targets
- Vitamin D receptor (keratinocytes): Agonist
Drugs in Topical vitamin D analogues (calcipotriol)
- Calcipotriol (calcipotriene) (Alone or with betamethasone.)
- Calcitriol ointment
Therapeutic uses
- Mild to moderate plaque psoriasis, including the scalp
Diseases it treats
Adverse effects
- Skin irritation, especially on the face and skin folds
- Hypercalcaemia if large areas are treated
Contraindications by condition
- Hypercalcaemia or disorders of calcium metabolism (Contraindicated): Absorbed drug raises calcium further.
- Treating large areas or with kidney impairment (Use with care): More is absorbed, raising calcium.
Connected topics
Written from
- Lippincott Illustrated Reviews: Pharmacology, 7th ed., Ch. 43, Drugs for Dermatologic Disorders, Psoriasis: topical agents
- Basic & Clinical Pharmacology (Katzung), 14th ed., Ch. 61, Dermatologic Pharmacology, Antipsoriatic agents
Educational reference. Not medical advice, diagnosis or treatment.